Literature DB >> 17189221

Multiple granulocytic sarcomas in essential thrombocythemia.

Yasuhiro Tanaka1, Yuya Nagai, Minako Mori, Haruyuki Fujita, Katsuhiro Togami, Masayuki Kurata, Akiko Matsushita, Akinori Maeda, Kenichi Nagai, Kyoko Tanaka, Takayuki Takahashi.   

Abstract

A 59-year-old woman was diagnosed with essential thrombocythemia in 1988 and had been treated with hydroxyurea, mitobronitol, busulfan, and ranimustine, in that order. Hepatosplenomegaly, low-grade fever, and body weight loss manifested, and a few blasts were noted in the peripheral blood studied in March 2002. A biopsied specimen of the bone marrow showed myelofibrosis but not a leukemia in August 2004. An abnormal karyotype with der(1; 13) appeared for the first time. She was treated with low-dose prednisolone. In January 2005, she experienced left hip joint pain, and magnetic resonance scanning showed a tumoral lesion in the femoral head. Histological diagnosis of the biopsied mass revealed that it was a granulocytic sarcoma, and radiotherapy was performed. In April 2005, bone scintigraphy showed multiple lesions. She became febrile and red blood cell transfusion-dependent with hepatosplenomegaly and a small number of circulating blasts. Intravenous cytarabine (low dose) and etoposide relieved the fever and hepatosplenomegaly; however, she developed a pathologic fracture of the right humerus. An additional karyotypic abnormality (7q22 deletion) was noted. She subsequently died of infection. Granulocytic sarcoma is very rare in essential thrombocythemia, and this patient may be the first reported case of essential thrombocythemia that developed multiple lesions and a pathologic fracture without transformation to overt leukemia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17189221     DOI: 10.1532/IJH97.06081

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  15 in total

1.  Essential thrombocythemia. Clinical characteristics and course of 61 cases.

Authors:  R Hehlmann; M Jahn; B Baumann; W Köpcke
Journal:  Cancer       Date:  1988-06-15       Impact factor: 6.860

2.  Cytogenetic studies in patients with secondary leukemia/dysmyelopoietic syndrome after different treatment modalities.

Authors:  J Whang-Peng; R C Young; E C Lee; D L Longo; G P Schechter; V T DeVita
Journal:  Blood       Date:  1988-02       Impact factor: 22.113

Review 3.  Efficacy and safety of hydroxyurea in patients with essential thrombocythemia.

Authors:  G Finazzi; T Barbui
Journal:  Pathol Biol (Paris)       Date:  2001-03

4.  Granulocytic sarcoma manifesting as multiple skeletal lesions.

Authors:  Mehdi Hamadani; Arafat Tfayli; Sanjay Sethi; Ahmed Awab; Najma Hamdani
Journal:  Am J Med Sci       Date:  2005-09       Impact factor: 2.378

Review 5.  Essential thrombocythemia: a retrospective study on the clinical course of 100 patients.

Authors:  A Chistolini; M G Mazzucconi; A Ferrari; G la Verde; G Ferrazza; F Dragoni; A Vitale; R Arcieri; F Mandelli
Journal:  Haematologica       Date:  1990 Nov-Dec       Impact factor: 9.941

6.  De novo appearance of der(1;7)(q10;p10) is associated with leukemic transformation and unfavorable prognosis in essential thrombocythemia.

Authors:  Hui-Hua Hsiao; Yoshikazu Ito; Goro Sashida; Junko H Ohyashiki; Kazuma Ohyashiki
Journal:  Leuk Res       Date:  2005-04-14       Impact factor: 3.156

7.  Acute myeloid leukemia and myelodysplastic syndromes following essential thrombocythemia treated with hydroxyurea: high proportion of cases with 17p deletion.

Authors:  Y Sterkers; C Preudhomme; J L Laï; J L Demory; M T Caulier; E Wattel; D Bordessoule; F Bauters; P Fenaux
Journal:  Blood       Date:  1998-01-15       Impact factor: 22.113

8.  Clinical course of essential thrombocythemia in 147 cases.

Authors:  P Fenaux; M Simon; M T Caulier; J L Lai; J Goudemand; F Bauters
Journal:  Cancer       Date:  1990-08-01       Impact factor: 6.860

9.  Primary Thrombocythemia in Japan: A Survey of 225 Patients.

Authors:  A Hattori; R Nagayama; K Kishi; I Fuse; M Hanano; S Takizawa; T Takeshige; A Shibata
Journal:  Leuk Lymphoma       Date:  1991

10.  Granulocytic sarcoma: a clinicopathologic study of 61 biopsied cases.

Authors:  R S Neiman; M Barcos; C Berard; H Bonner; R Mann; R E Rydell; J M Bennett
Journal:  Cancer       Date:  1981-09-15       Impact factor: 6.860

View more
  2 in total

1.  Myeloid sarcoma in essential thrombocythemia that transformed into acute myeloid leukemia.

Authors:  Hisaharu Shikata; Takuya Matumoto; Hiroki Teraoka; Masahiko Kaneko; Mamoru Nakanishi; Tadashi Yoshino
Journal:  Int J Hematol       Date:  2009-01-27       Impact factor: 2.490

2.  Epigenomic analysis of KLF1 haploinsufficiency in primary human erythroblasts.

Authors:  Joseph Borg; Emile van den Akker; Sjaak Philipsen; Steven Heshusius; Laura Grech; Nynke Gillemans; Rutger W W Brouwer; Xander T den Dekker; Wilfred F J van IJcken; Benjamin Nota; Alex E Felice; Thamar B van Dijk; Marieke von Lindern
Journal:  Sci Rep       Date:  2022-01-10       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.